Summary
Differentials
Common
- Alcohol induced
- Hepatic steatosis
- Primary biliary cholangitis (PBC)
- Primary sclerosing cholangitis
- Hemochromatosis
- Hodgkin lymphoma
- Non-Hodgkin lymphoma (NHL)
- Waldenström macroglobulinemia or lymphoplasmacytic lymphoma
- Acute myeloid leukemia (AML)
- Chronic myeloid leukemia (CML)
- Acute lymphoblastic leukemia (ALL)
- Chronic lymphocytic leukemia (CLL)
- Hairy cell leukemia
- Myelofibrosis
- Polycythemia vera
- Essential thrombocytosis
- Splenic metastases
- Autoimmune hemolytic anemia
- Rheumatoid arthritis (RA)
- Felty syndrome
- Systemic lupus erythematosus
- Sarcoidosis
- Malaria
- Epstein-Barr virus (EBV)
- Endocarditis
- Sepsis-related splenic abscesses
- Chronic hepatitis C
- Chronic hepatitis B
- Sickle cell anemia
- Cytoskeletal defects
- Thalassemias
Uncommon
- Benign splenic tumors
- Portal vein thrombosis
- Splenic vein thrombosis
- Budd-Chiari syndrome
- Hemophagocytic lymphohistiocytosis (HLH)
- Amyloidosis
- Gaucher or Niemann-Pick disease
- Severe dengue
- Splenic rupture
- Subcapsular hemorrhage
- Secondary to granulocyte colony-stimulating factor (G-CSF)
Contributors
Authors
Terri L. Parker, MD
Assistant Professor of Medicine
Section of Hematology
Yale School of Medicine
Smilow Cancer Center at Yale-New Haven
New Haven
CT
Disclosures
TLP declares that she has no competing interests.
Acknowledgements
Dr Terri L. Parker would like to gratefully acknowledge Dr Alan E. Lichtin, the previous contributor to this monograph.
Disclosures
AEL has received research support from Amgen.
Peer reviewers
Priyanka Mehta, MD
Consultant Haematologist
Bristol Haematology and Oncology Centre
Bristol
UK
Disclosures
PM declares that she has no competing interests.
Ruben A. Mesa, MD
Professor of Medicine
Mayo Clinic
Scottsdale
AZ
Disclosures
RAM declares that he has no competing interests.
Giovanni Barosi, MD
Director of the Laboratory of Clinical Epidemiology
IRCCS Policlinico S. Matteo Foundation
Pavia
Italy
Disclosures
GB declares that he has no competing interests.
References
Key articles
Gertz MA. Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management. Am J Hematol. 2023 Feb;98(2):348-58.Full text Abstract
Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022 Jul;36(7):1720-48.Full text Abstract
Shakoory B, Geerlinks A, Wilejto M, et al. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. 2023 Oct;82(10):1271-85.Full text Abstract
Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Patient information
Hepatitis B: should I have the vaccine?
Hepatitis C: what is it?
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer